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Background: We previously proposed an algorithm for the identification of GO terms that commonly annotate genes
whose expression is upregulated or downregulated in some microarray data compared with in other microarray data.
We call these “differentially expressed GO terms” and have named the algorithm “matrix-assisted identification method
of differentially expressed GO terms” (MIMGO). MIMGO can also identify microarray data in which genes annotated with
a differentially expressed GO term are upregulated or downregulated. However, MIMGO has not yet been validated on
a real microarray dataset using all available GO terms.
Findings: We combined Gene Set Enrichment Analysis (GSEA) with MIMGO to identify differentially expressed GO terms
in a yeast cell cycle microarray dataset. GSEA followed by MIMGO (GSEA + MIMGO) correctly identified (p < 0.05)
microarray data in which genes annotated to differentially expressed GO terms are upregulated. We found that GSEA +
MIMGO was slightly less effective than, or comparable to, GSEA (Pearson), a method that uses Pearson’s correlation as a
metric, at detecting true differentially expressed GO terms. However, unlike other methods including GSEA (Pearson),
GSEA + MIMGO can comprehensively identify the microarray data in which genes annotated with a differentially
expressed GO term are upregulated or downregulated.
Conclusions: MIMGO is a reliable method to identify differentially expressed GO terms comprehensively.Findings
Background
Microarray technologies allow simultaneous monitoring
of the expression of thousands of genes [1]. Many
groups have produced microarray datasets for various
research topics of interest. Currently, many microarray
datasets are deposited in databases such as the Gene
Expression Omnibus [http://www.ncbi.nlm.nih.gov/geo/]
[2]. These datasets often contain time-course or tissue
microarray data. The first step in the analysis of such
microarray datasets often involves the identification of
genes whose expression is upregulated or downregulated
in specific microarray data when compared with the ex-
pression levels in other microarray data [3,4]. Further-
more, to understand the biological implications of
differentially expressed genes, biological annotations that* Correspondence: youichi@t.kanazawa-u.ac.jp
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reproduction in any medium, provided the orare significantly enriched among the differentially
expressed genes are often identified. Gene Ontology
(GO) and the KEGG PATHWAY database provide over
30,000 biological gene annotations (GO terms) and a
few hundred pathway gene annotations, respectively
[5,6].
Many tools have been developed to identify the bio-
logical annotations that are significantly enriched in dif-
ferentially expressed genes [7,8]. Of these, Gene Set
Enrichment Analysis (GSEA) is a powerful method to
determine whether an a priori-defined set of genes (e.g.,
genes annotated with the same GO term) shows statisti-
cally significant, concordant expression differences be-
tween two distinct microarray data [9].
Furthermore, there are several methods (i.e., gene set
analysis methods) to identify GO terms that commonly
annotate genes whose expression is upregulated or
downregulated in particular microarray data compared
with their expression levels in other microarray data.
Hereafter, we refer to these GO terms as “differentiallyl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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http://www.biomedcentral.com/1756-0500/5/680expressed GO terms” (see Figure 1). As mentioned
above, one of these methods is annotation-enrichment
analysis after identification of differentially expressed
genes, but this has several problems [9-11]. Although
the other methods do not have such problems, these
others require pre-specification (e.g., 1 for a disease and
0 for a normal) of microarray data in which genes anno-
tated with a differentially expressed GO term are upre-
gulated or downregulated, or cannot identify these
microarray data [9-15]. Hereafter, we refer to these
microarray data with the differential expression as
“de_microarray_data”. To address these issues, we previ-
ously proposed an algorithm that can identify not only
differentially expressed GO terms but also de_microar-
ray_data [16]. We named this algorithm “matrix-assisted
identification method of differentially expressed GO
terms” (MIMGO). For each GO term, MIMGO initially
prepares a matrix that mutually compares each micro-
array data pair in a microarray dataset (Figure 2). Then,
GO terms that commonly annotate differentially
expressed genes between each pair of microarray data
are identified using a tool such as GSEA (Figure 2). Fi-
nally, using the matrix, MIMGO identifies differentially
expressed GO terms and de_microarray_data (Figure 2).
In our previous report, we applied a simple fold change
method to identify differentially expressed genes between
each microarray data pair in a yeast cell cycle microarray
dataset, and tested the statistical significance of GO term
annotations to the differentially expressed genes [16].
Ultimately, MIMGO identified differentially expressed GO
terms and de_microarray_data. However, we estimated its
















Figure 1 Differentially expressed GO terms and non-differentially exp
term. Identifiers (I–VIII) on the horizontal axis show the microarray data. The
data. Genes A–F are annotated with a differentially expressed GO term and
are annotated to a differentially expressed GO term are similarly upregulate
their expression levels in other microarray data. B, an example of a non-dif
show the microarray data. The vertical axis shows the expression of genes
differentially expressed GO term and are upregulated in mutually different
annotated with a non-differentially expressed GO term are upregulated orMIMGO can be applied reliably to an actual microarray
dataset using all available GO terms, it should be validated
as to whether it can correctly identify differentially
expressed GO terms and de_microarray_data.
Here, we combined GSEA with MIMGO to identify




To identify differentially expressed GO terms, we used a
time-course microarray dataset in which yeast cells were
synchronized by α-factor, as in our previous study
[16,17]. Yeast cells were periodically recovered after re-
lease from G1 arrest using α-factor. Asynchronous yeast
cells growing under the same culture conditions were
recovered at the same time-points for use as controls.
RNA from experimental and control yeast cells was
extracted using the same method. Fluorescently labeled
cDNA was synthesized from each extracted RNA, and
the ratio of experimental to control cDNA was mea-
sured at each recovery time-point. The expression ratio
of each gene was subjected to logarithmic con-
version. These logarithmic values were returned to the
former values by the exponential function with base 2.
The dataset includes 6,019 genes and 18 microarray
data.
GSEA
GSEA software was downloaded from the Gene Set En-
richment Analysis website [http://www.broad.mit.edu/
















ressed GO terms. A, an example of a differentially expressed GO
vertical axis shows the expression of genes A–F in the microarray
are similarly upregulated in microarray data II and VI. Thus, genes that
d or downregulated in specific microarray data when compared with
ferentially expressed GO term. Identifiers (I–VIII) on the horizontal axis
G–L in the microarray data. Genes G–L are annotated with a non-
microarray data (i.e., discordant upregulation). Thus, genes that are
downregulated in mutually different microarray data.
Identification of differentially expressed GO terms 
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average + standard deviation
(avg + std)
Comparative verification
Figure 2 Validation-flow chart of GSEA + MIMGO. Eighteen row- and 18 column-indices labeled by time-points (0, 7, 14, etc.) in a matrix of
step 1 show the time-course microarray data. GSEA determines whether a gene set assigned a GO term is differentially expressed between row-
and column-indices in the matrix of step 1. Log2_Ratio_of_Classes is used as a metric for GSEA. In step 2, MIMGO identifies differentially
expressed GO terms using the matrix of step 1. To investigate whether the “microarray data with upregulation” identified by GSEA + MIMGO are
correct, the results obtained from GSEA + MIMGO are compared with the average expression level of genes annotated with a GO term for each
microarray result. In the square below, the average expression of a gene set annotated with a GO term exceeds the sum of its average and
standard deviation only at 14 min, 21 min, 70 min, and 77 min. Therefore, these time-points are marked with 1 in “> (avg + std)”. GSEA (Pearson)
shows GSEA using Pearson correlation as metrics. Ideal expression pattern in the time-course microarray data (0 min, 7 min, 14 min, etc.) is
prepared as a phenotype label. Pearson correlation coefficients are calculated between the ideal expression pattern and actual gene expressions.
The GO term associated with a gene set showing a high Pearson correlation is identified as a differentially expressed GO terms. Finally, “GSEA +
MIMGO” is compared with GSEA (Pearson) for identification of true differentially expressed GO terms.
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using the gene_association.sgd and gene_ontology.1_2.obo
files downloaded from the Gene Ontology website [http://
www.geneontology.org/]. For the GSEA parameters,
“1000”, “gene_set”, “weighted”, and “log2_Ratio_of_-
Classes” were selected as “Number of permutations”,
“Permutation type”, “Enrichment statistic”, and “Metric
for ranking genes”, respectively.
GSEA was conducted for each recovery time-point-
derived microarray data pair (e.g., 0 min vs. 7 min, 0
min vs. 14 min, 105 min vs. 119 min, 112 min vs. 119
min) from the yeast microarray dataset synchronized by
α-factor (see MIMGO below). GO terms (i.e., upregu-
lated GO terms) showing a false discovery rate (FDR)q-value below a threshold were identified for each
microarray data pair.
MIMGO
To perform pair-wise comparisons between the microarray
data, we prepared a matrix for use in MIMGO for each
GO term, as shown in Figure 3A. Suppose that the matrix
in Figure 3A is prepared for GO term “A”, and eight
microarray data (I–VIII) are compared with each other in
the matrix. Following calculation of all gene expression
ratios in the row index to the column index for each cell in
a matrix, GSEA for the GO term assigned to the matrix
was conducted in each cell, excluding those cells marked
with a diagonal line. For example, following calculation of
I II III IV V VI VII VIII
I * 1 1
II 1 1 1 1 1 1 1
III 1 1
IV 1




I II III IV V VI VII VIII
GSEA + MIMGO 0 1 0 0 1 0 0 0






I II III IV V VI VII VIII
A B
C
Figure 3 GSEA + MIMGO and validation of the identified “microarray data with upregulation”. A, Matrix for pair-wise comparison between
microarray data. This matrix is prepared for GO term “A”. Identifiers (I–VIII) in the first row and column show the microarray data. The asterisk
describes the relative fold inductions of each gene in microarray data I to II. The cells marked with 1 indicate that GO term “A” annotates
significantly more upregulated genes in its row identifier than in its column identifier. B, The average expression of genes annotated with GO
term “A” in each microarray result. Each number (I–VIII) on the horizontal axis represents a microarray result. The solid line represents the average
expression of genes annotated with GO term “A” in each microarray result. The dotted line describes the sum of the average and the standard
deviation for the average expression (i.e., diamond marks on the solid line) of genes annotated with GO term “A” in all the microarray data (I–VIII).
C, Validation of “microarray data with upregulation” identified by GSEA + MIMGO. Each number (I–VIII) represents a microarray result. When a
statistically significant number of cells marked with 1 is in a row of a matrix as in Figure 3A, the corresponding cell of “GSEA + MIMGO” in
Figure 3C is marked with 1. Microarray data that show a value above the dotted line in Figure 3B are marked with 1 in “> (avg + std)” of
Figure 3C.
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for a gene set that is assigned to GO term “A” would be
conducted in the asterisked cell of Figure 3A.
When a GO term showed a q-value of GSEA below a
threshold, the corresponding cell in the matrix prepared
for that GO term was marked with 1. For instance, when
GO term “A” showed a q-value of GSEA below a thresh-
old in microarray I to II in Figure 3A, the asterisked cell
in Figure 3A would be marked with 1. Similarly, the
same process was repeated in the other cells, except for
self-comparisons. In the example, the same process
would be repeated in all cells except those marked with
a diagonal line in Figure 3A.
To examine whether cells marked with 1 are enriched
in any rows compared with in the whole matrix, we used
Fisher’s exact test. Here, the null hypothesis is that the
proportion of cells marked with 1 out of the total num-
ber of cells in a particular row is not different from that
in the complement of that row. The null hypothesis was







in which N is the number of cells in the matrix except
the self-comparisons, M is the number of cells markedwith 1 in the N, n is the number of cells in a row except
the self-comparisons, and x is the number of cells
marked with 1 in the row. An FDR correction was ap-
plied to the results of these multiple comparisons using
the following equation:
False discovery rate %ð Þ ¼ 100MC  p
PN
ð2Þ
in which MC is the number of multiple comparisons, p
is the p-value in equation 1, and PN is the number of
rows that displayed a p-value less than 0.05 in equation 1.
Rows showing an FDR lower than 5% were identified as
rows significantly enriched with 1. For example, because
cells marked with 1 are enriched in the rows of microar-
rays II and V (Figure 3A), the rows of microarrays II and
V show p-values of 8.39E-05 and 2.17E-03, and FDRs of
0.0335% and 0.866%, respectively. Thus, GO term “A” is
identified as a differentially expressed GO term that is
upregulated in microarray data II and V. Similarly, GO
terms showing at least one significantly enriched row of
cells marked with 1 are identified as differentially expressed
GO terms.
Note that there are two multiple comparisons in
GSEA + MIMGO: one is multiple comparisons by
GSEA, the other is multiple comparisons by Fisher’s
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only to the multiple comparisons by Fisher’s exact test
in MIMGO.
Validation of “microarray data with upregulation” and
“microarray data with no upregulation” identified by
GSEA + MIMGO
To investigate whether “microarray data with upregula-
tion” (de_microarray_data) identified by GSEA +
MIMGO were correct, we compared our results with
the average expression level of genes annotated with a
GO term in each microarray result (Figure 2). For this,
the average expression of genes assigned a GO term was
first calculated for each time-point-labeled microarray
result (e.g., 0 min, 7 min, 14 min). For example, the solid
line in Figure 3B shows the average expression of genes
annotated with GO term “A” in microarray data I–VIII.
Then, the average (Avg_of_A) and standard deviation
(Std_of_A) of the average expression levels (diamond
marks on the solid line) were calculated. For example,
the dotted line in Figure 3B shows the sum of Avg_of_A
and Std_of_A in microarray data I–VIII. If the average
expression of genes annotated with a GO term was
higher than the sum of Avg_of_A and Std_of_A, the cor-
responding microarray result was marked with 1. For ex-
ample, because the average expression in microarray
data II and V is higher than the sum (dotted line) of
Avg_of_A and Std_of_A in Figure 3B, the cells of II and
V are marked with 1 in “> (avg + std)” of Figure 3C. On
the other hand, a row of cells significantly enriched with
1 in MIMGO was marked with 1 in a comparison matrix
such as that shown in Figure 3C. For example, micro-
array data significantly enriched for cells marked with 1
in Figure 3A (i.e., II and V) are labeled with 1 in “GSEA
+ MIMGO” of Figure 3C. Then, the Pearson correlation
coefficient was calculated between “GSEA + MIMGO”
and “> (avg + std)” in Figure 3C. This calculation was
conducted for all GO terms identified as differentially
expressed GO terms by MIMGO. A high correlation co-
efficient in this calculation suggests that the de_microar-
ray_data identified by GSEA + MIMGO are roughly
valid. Because “> (avg + std)” in Figure 3C does not ne-
cessarily correspond to correct answers, this validation
of GSEA + MIMGO simply serves as an indication, and
does not necessarily connote a sufficient condition.
Comparison of GSEA + MIMGO and GSEA (Pearson) for the
identification of true differentially expressed GO terms
To compare GSEA + MIMGO with GSEA (Pearson), a
method that uses Pearson's correlation as a metric, we
selected three sets of GO terms as true differentially
expressed GO terms from all the GO terms (N = 3,474).
The first was a set of GO terms (N = 7) in which half of
their associated genes show r1 ≥0.6 and the other halfshow r1 <0.6, where r1 is the Pearson correlation coeffi-
cient of the gene expression and the vector “0 0 1 1 0 0 0
0 0 0 1 1 0 0 0 0 0 0” (1 only for 14 min, 21 min, 70 min,
and 77 min). The second was a set of GO terms (N = 22)
in which half of their associated genes show r2 ≥0.6, where
r2 is the Pearson correlation coefficient of the gene ex-
pression and the vector “0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0
0” (1 only for 7 min, 14 min, and 21 min). The third was a
set of GO terms (N = 5) in which half of their associated
genes show r3 ≥0.6, where r3 is the Pearson correlation
coefficient of the gene expression and the vector “1 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0” (1 only for 0 min). When separate
GO terms were found to annotate an identical gene set,
they were merged into one GO term. Furthermore, when
a GO term was found to annotate fewer than three genes,
it was removed from the list of true differentially
expressed GO terms.
We then examined whether these two methods could
detect these true differentially expressed GO terms.
GSEA + MIMGO was conducted for all the GO terms
(N = 3,474), including the three GO term sets, using a
GSEA q-value threshold of 0.05. When any row in the
matrix showing an FDR lower than 5% in equation (2)
was identified for each GO term, we determined that
GSEA + MIMGO detected that GO term as a differen-
tially expressed GO term.
GSEA (Pearson) was also conducted for all the GO
terms (N = 3,474) using three continuous phenotype labels
(ideal gene expression): “0 0 1 1 0 0 0 0 0 0 1 1 0 0 0 0 0
0” for GO terms upregulated at 14 min, 21 min, 70 min,
and 77 min; “0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0” for GO
terms upregulated at 7 min, 14 min, and 21 min; and “1 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0” for GO terms upregulated
at 0 min (Figure 2). When each of the three sets of GO
terms showed GSEA q-values less than 0.05 in the corre-
sponding continuous phenotype label, we determined that
GSEA (Pearson) identified those GO terms as differen-
tially expressed GO terms.
Results and discussion
We used GSEA followed by MIMGO (GSEA + MIMGO)
on a yeast cell cycle microarray dataset [17] to identify dif-
ferentially expressed GO terms. Because the expression
level of many genes periodically oscillates during the cell
cycle, we expected to identify many differentially expressed
GO terms that annotate these genes.
Figure 2 shows a flow chart for GSEA + MIMGO and
its validation in comparison with other methods. We first
prepared a matrix for each GO term (Figure 3A). Because
the yeast cell cycle microarray dataset contains 18 micro-
array data obtained at 7-min intervals, the matrices con-
tain 18 row- and 18 column-indices labeled by time-point
(0 min, 7 min, 14 min, etc.). GSEA was then performed on
each row index to each column index of the matrices, and
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GSEA q-value below the threshold, the corresponding cell
was marked with 1 (Figure 3A). Then, MIMGO was ap-
plied to each matrix, and GO terms that had at least one
row enriched for cells marked with 1 were identified as
differentially expressed GO terms (Figure 3A). A row
enriched with cells marked with 1 meant that genes asso-
ciated with the GO term assigned to that matrix showed
higher expression in that microarray result than in other
microarray data. Conversely, a column enriched with cells
marked with 1 denoted that genes associated with the GO
term assigned to that matrix showed lower expression in
that microarray result than in other microarray data.
“Number of GO terms” in Table 1 shows the number
of differentially expressed GO terms identified at each
q-value threshold of GSEA. As the GSEA q-value thresh-
old increased, more differentially expressed GO terms
were identified.
In contrast to other methods, GSEA + MIMGO can
identify microarray data (de_microarray_data) in which
genes annotated with a differentially expressed GO term
are upregulated. Accordingly, we verified the de_microar-
ray_data using an indicator obtained from another
method.
For this reason, we first prepared a matrix equivalent
to Figure 3C for each differentially expressed GO term.
We then calculated the average and the standard devi-
ation of the average expression levels (diamond marks on
the solid line in Figure 3B) for the gene set annotated
with a differentially expressed GO term in the 18 micro-
array data. When the average expression in each micro-
array result exceeded the sum of their average and
standard deviation, the corresponding cells were labeledTable 1 Validation of all differentially expressed GO
terms identified by GSEA + MIMGO at each GSEA q-value
threshold
GSEA q-value threshold 0.02 0.05 0.1 0.2
number of GO terms 302 452 687 1024
average correlation 0.65 0.67 0.67 0.66
standard deviation 0.25 0.23 0.25 0.25
minimum correlation −0.16 −0.13 −0.15 −0.19
correlation >0.9 53 91 131 194
correlation <0.1 14 14 28 43
“GSEA q-value threshold” shows the q-value thresholds used in GSEA. “number
of GO terms” denotes the total number of differentially expressed GO terms
identified at each GSEA q-value threshold. “average correlation” represents the
average correlation coefficient between “GSEA + MIMGO” and “> (avg + std)”
in Figure 3C for all differentially expressed GO terms identified at each GSEA
q-value threshold. “standard deviation” describes the standard deviations of
the correlation coefficient for all differentially expressed GO terms identified at
each GSEA q-value threshold. “minimum correlation” shows the minimum of
the correlation coefficient for all differentially expressed GO terms identified at
each GSEA q-value threshold. “correlations >0.9” and “correlations <0.1” show
the total numbers of differentially expressed GO terms showing the correlation
coefficient over 0.9 and under 0.1, respectively, for all differentially expressed
GO terms identified at each GSEA q-value threshold.with 1, as shown by “> (ave + std)” in Figure 3C. On the
other hand, rows enriched with cells marked with 1 in
the matrix of Figure 3A were also marked with 1, as
shown by “GSEA + MIMGO” in Figure 3C. Then, the
Pearson correlation coefficient was calculated between
“GSEA + MIMGO” and “> (avg + std)” for each differen-
tially expressed GO term (see Figure 3C). Note that we
converted the vector of average gene expression across
the microarray data to a bit vector of “upregulation” (i.e.,
1) and “no upregulation” (i.e., 0) because “microarray
data showing upregulation”, but not the expression dif-
ference between microarray data showing upregulation
or no upregulation, is important to validate the de_mi-
croarray_data from GSEA + MIMGO. Furthermore, be-
cause “> (avg + std)” generally reminded us of significant
upregulation in part of a microarray data set, we used the
sum of the average and standard deviation as an indicator
of upregulation. The resulting high correlation coefficient
suggests that GSEA + MIMGO could identify upregula-
tion of differentially expressed GO terms at roughly cor-
rect microarray data.
“Average correlation” in Table 1 showed similar high
correlations (0.65–0.67) at all q-value thresholds of GSEA.
In contrast, as shown in “correlations >0.9” and “correla-
tions <0.1” in Table 1, the total numbers of correlation
coefficients above 0.9 and lower than 0.1 tended to in-
crease upon an increasing q-value threshold of GSEA. Be-
cause a GSEA q-value threshold of 0.05 showed better
values for “average correlation”, “standard deviation”,
“minimum correlation”, and “correlations <0.1” than the
other GSEA q-value thresholds did, it may be relatively su-
perior at identifying differentially expressed GO terms
(Table 1). Therefore, when we compared GSEA +
MIMGO with GSEA (Pearson), we used a GSEA q-value
threshold of 0.05 for GSEA + MIMGO (see Figure 2).
Although it is difficult to determine the enrichment of
cells marked with 1 in each row of a matrix in Figure 3A
at each GSEA q-value threshold, the results from “GSEA
+ MIMGO” and “> (avg + std)” showed the average correl-
ation higher than 0.65 (p < 0.05) at all GSEA q-value
thresholds (Table 1). This result suggested that GSEA
+ MIMGO could correctly identify de_microarray_data.
All the matrices of Figure 3C for differentially
expressed GO terms identified at GSEA q-value thresh-
olds 0.02 and 0.2 are described in Additional file 1
(Additional file 1: Table S1).
Because the total number of differentially expressed GO
terms identified varied considerably with the GSEA q-value
threshold (Table 1), we examined whether the differentially
expressed GO terms identified at a GSEA q-value threshold
of 0.02 were also identified at other q-value thresholds
(Table 2). Although some differentially expressed GO terms
showed no statistical significance in any matrix row at some
q-value thresholds, at least 286 GO terms showed an
Table 2 Validation of differentially expressed GO terms
identified at a GSEA q-value threshold of 0.02
GSEA q-value threshold 0.02 0.05 0.1 0.2
number of GO terms 302 289 288 286
average correlation 0.65 0.72 .074 0.76
standard deviation 0.25 0.22 0.22 0.21
minimum correlation −0.16 −0.11 −0.13 −0.19
correlation >0.9 53 72 77 82
correlation <0.1 14 5 4 3
We examined whether the 302 differentially expressed GO terms
(0.02_de_GO_terms) identified at a GSEA q-value threshold of 0.02 were also
identified at the other GSEA q-value thresholds. “GSEA q-value threshold”
shows the q-value thresholds used in GSEA. “number of GO terms” denotes
the total number of 0.02_de_GO_terms identified at each GSEA q-value
threshold. “average correlation” represents the average correlation coefficient
between “GSEA + MIMGO” and “> (avg + std)” in Figure 3C for all
0.02_de_GO_terms identified at each GSEA q-value threshold. “standard
deviation” describes the standard deviation of the correlation coefficient for all
0.02_de_GO_terms identified at each GSEA q-value threshold. “minimum
correlation” shows the minimum of the correlation coefficient for all
0.02_de_GO_terms identified at each GSEA q-value threshold. “correlation
>0.9” and “correlation <0.1” show the total numbers of 0.02_de_GO_terms
showing the correlation coefficient over 0.9 and under 0.1, respectively, for all
0.02_de_GO_terms identified at each GSEA q-value threshold.
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each GSEA q-value threshold (see “number of GO terms”
in Table 2). In contrast to Table 1, “average correlation” in
Table 2 increased upon an increasing q-value threshold of
GSEA. Thus, Tables 1 and 2 suggest that the best q-value
threshold varies by the differentially expressed GO term.
An example of differentially expressed GO terms in
which the average correlation increases upon an increasing
q-value threshold of GSEA is shown in Figure 4A.
Figure 4A shows detailed validation of results from GSEA
+ MIMGO for the GO term “S phase” that annotates 20
genes. Because “S phase” displays two relatively distinct
peaks in the average expression of its associated genes
across the time-course (Figure 4A-(II)), 14 min, 21 min, 70
min, and 77 min in “> (avg + std)” of Figure 4A-(III) and
-(IV) are marked with 1. A GSEA q-value threshold of 0.02
is too stringent for “S phase” to have enough cells marked
with 1 in the “21 min” row in the bottom matrix of
Figure 4A-(III). Accordingly, the cell marked with 21 in
“GSEA + MIMGO” of Figure 4A-(III) has a value of 0. In
contrast, a GSEA q-value threshold of 0.2 is minimally
stringent so that “S phase” showed enough cells marked
with 1 in the “21 min” row in the bottom matrix of
Figure 4A-(IV), resulting in “1” in the “21 min” cell of
“GSEA + MIMGO” of Figure 4A-(IV). Furthermore, when
the expression of genes annotated with “S phase” was
examined separately, it displayed two concerted upregula-
tions across a microarray dataset, similar to that in
Figure 1A.
Thus, the higher average correlation at higher q-value
thresholds in Table 2 may result from fewer cells marked
with 1 in the matrices equivalent to Figure 3A for a subsetof differentially expressed GO terms at lower q-value
thresholds. The alternative view is that this result may be
simply because of the increased number of cells containing
“1” in a “GSEA + MIMGO” row. Because the vector for
“> (avg + std)” generally has few “1” values, the number of
GO terms with a correlation coefficient below zero tends to
decrease when the vector “GSEA + MIMGO” contains
many “1” values.
Finally, we examined two differentially expressed GO
terms that displayed minimum correlations at GSEA
q-value thresholds of 0.02 and 0.2 in Table 1. The GO term
that displayed the minimum correlation of −0.16 at a GSEA
q-value threshold of 0.02 in Table 1 was “Cellular cell wall
organization”, which annotates 213 genes (Figure 4B).
“Cellular cell wall organization” showed a high correlation
of 0.6 only at a GSEA q-value threshold of 0.2 (Figure
4B-(I)) and a mild expression change across the time-
course (Figure 4B-(II)). Although a few cells are marked
with 1 in the bottom matrix of Figure 4B-(III), “GSEA +
MIMGO” showed “1” in completely different cells from “>
(avg + std)” in the upper matrix of Figure 4B-(III), unlike
Figure 4A-(III). The algorithm difference between “GSEA +
MIMGO” and “> (avg + std)” could cause this difference,
but it is suggested that GO terms that have few cells
marked with 1 in the matrices equivalent to Figure 3A
should not be identified as differentially expressed GO
terms because they display upregulation for only a portion
of the microarray dataset (Figure 4B-(III)). In this case, only
the set with a stricter threshold in equation (2) cannot pre-
vent MIMGO from identifying “Cellular cell wall
organization” as a differentially expressed GO term because
there are only a few cells marked with 1 in the bottom
matrix of Figure 4B-(III). For example, when there are six
cells marked with 1 in the bottom matrix of Figure 4B-(III)
and three cells marked with 1 in a row, the p-value for the
row in equation (1) is 0.0025. Furthermore, when each of
the remaining three cells marked with 1 is in a different
row, the FDR for the row in equation (2) is 0.38%. We can-
not generally set such a strict threshold for the FDR. There-
fore, MIMGO should be performed only when a matrix
such as that in Figure 3A has a sufficient number of cells
marked with 1.
In contrast, the total number of cells marked with 1
increases in the bottom matrix of Figure 4B-(IV) com-
pared with that of Figure 4B-(III), resulting in markings of
1 at roughly equal time-points between “GSEA +
MIMGO” and “> (avg + std)” in the upper matrix of
Figure 4B-(IV). This also shows that a q-value threshold of
0.02 is too stringent for “Cellular cell wall organization” to
show “1” in appropriate cells in the upper matrix of
Figure 4B-(III). However, when the expression of genes
annotated with “Cellular cell wall organization” was exam-
ined separately, none displayed any concerted upregula-
tion across the microarray dataset (data not shown). In
Average expressionA (I) (II)
(III) (IV)
B Average expression(I) (II)
(IV)(III)
C Average expression(I) (II)
(IV)(III)
Figure 4 (See legend on next page.)
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Figure 4 Detailed validation of results from GSEA + MIMGO for three GO terms. Detailed results from GSEA + MIMGO for three GO terms
(A, S phase; B, Cellular cell wall organization; C, Regulation of cell shape) are shown. Each (I) in A–C shows the correlation coefficient between
“GSEA + MIMGO” and “> (avg + std)” in Figure 3C for the three GO terms at each GSEA q-value threshold. Each (II) in A–C describes the average
expression of genes annotated with the three GO terms in each microarray result (i.e., 0–119 min). The upper and lower diagrams in each (III)
describe the matrices of Figure 3C and 3A, respectively, for the three GO terms at a GSEA q-value threshold of 0.02. The upper and lower
diagrams in each (IV) depict the matrices of Figures 3C and 3A, respectively, for the three GO terms at a GSEA q-value threshold of 0.2. The 0, 7,
14, etc. in (III) and (IV) denote the recovery time-point labels for each microarray result.
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the bottom matrix of Figure 4B-(IV), the set that uses a
stricter threshold in equation (2) prevents MIMGO from
identifying “Cellular cell wall organization” as a differen-
tially expressed GO term at a GSEA q-value threshold
of 0.2.
The GO term that displayed the minimum correlation
(−0.19 at a q-value threshold of 0.2 in Table 1) was “Regula-
tion of cell shape”, which annotates 17 genes (Figure 4C).
Furthermore, the correlation coefficient at all GSEA q-value
thresholds showed negative values (Figure 4C-(I)). When
the expression of genes annotated with “Regulation of cell
shape” was examined separately, none displayed any con-
certed upregulation across the microarray dataset, similar
to in Figure 1B. As previously explained, to avoid identify-
ing “Regulation of cell shape” as a differentially expressed
GO term at a lower GSEA q-value threshold, MIMGO
should be performed only when a matrix such as that in
Figure 3A has a sufficient number of cells marked with 1;
for “Regulation of cell shape” there are only a few cells
marked with 1 in the bottom matrix of Figure 4C-(III). In
addition, the set that uses a stricter threshold in equation
(2) will prevent MIMGO from identifying “Regulation of
cell shape” as a differentially expressed GO term at a higher
GSEA q-value threshold because there are relatively many
cells marked with 1 in the bottom matrix of Figure 4C-(IV).
We next examined whether GSEA + MIMGO can iden-
tify true differentially expressed GO terms. Furthermore,
we compared its results with those generated using GSEA
(Pearson) that used Pearson's correlation as a metric, as
shown in Figure 2. As shown in Table 3, the proportions ofTable 3 Comparison of GSEA + MIMGO and GSEA (Pearson) fo
expressed GO terms
7 GO terms upregulated at 14min, 21min
70min, 77min
GSEA + MIMGO 2 / 7 (28%)
GSEA (Pearson) 2 / 7 (28%)
GO terms identified in both
methods
1
The sets of GO terms are described in detail in the text. “GSEA + MIMGO” and “GSE
were detected by GSEA + MIMGO and GSEA (Pearson) for each set of true different
shows the number of the true differentially expressed GO terms identified in both Gtrue differentially expressed GO terms identified were low
for both methods, indicating the general disadvantage of
GSEA for detecting this type of true differentially expressed
GO terms. Dinu et al. also indicated that GSEA is poor at
detecting differentially expressed GO terms that equally
annotated both highly correlated genes and weakly corre-
lated genes with an ideal expression pattern [13]. Accord-
ingly, the low power of both methods may result from the
GSEA algorithm.
Both methods were able to identify a similar proportion
of true differentially expressed GO terms for each set of
GO terms prepared (Table 3). However, GSEA (Pearson)
was superior to GSEA + MIMGO in its identification rate
of true differentially expressed GO terms for the second set
("22 GO terms upregulated at 7 min, 14 min, and 21 min").
In addition, almost all the true differentially expressed GO
terms identified were identical between the two methods
(Table 3). This suggests that GSEA + MIMGO was com-
parable to, but in some instances slightly less powerful than,
GSEA (Pearson) at identifying differentially expressed GO
terms (Table 3). However, GSEA + MIMGO can compre-
hensively identify differentially expressed GO terms without
the need to set continuous phenotype labels such as “ideal
expression pattern” (Figure 2). On this point, GSEA +
MIMGO has an advantage over GSEA (Pearson).
Figure 5 shows two true differentially expressed GO
terms (A: “DNA synthesis involved in DNA repair”,
B: “replication fork protection”) identified by either
GSEA + MIMGO or GSEA (Pearson) for the first set
(“7 GO terms upregulated at 14 min, 21 min, 70 min,
and 77 min”) in Table 3. GSEA + MIMGO, but notr the identification of three sets of true differentially
, 22 GO terms upregulated at 7min,
14min, 21min
5 GO terms upregulated
at 0min
7 / 22 (31%) 1 / 5 (20%)
11 / 22 (50%) 1 / 5 (20%)
6 1
A (Pearson)” denote proportion of true differentially expressed GO terms that
ially expressed GO terms, respectively. ”GO terms identified in both methods"































































































































































Figure 5 Two true differentially expressed GO terms identified by either GSEA + MIMGO or GSEA (Pearson). A, expression of genes
annotated to “DNA synthesis involved in DNA repair”. This is a true differentially expressed GO term that GSEA + MIMGO, but not GSEA (Pearson),
was able to identify in the first set (“7 GO terms upregulated at 14 min, 21 min, 70 min, and 77 min”) of Table 3. The vertical axis shows the
expression of genes (YKL113C, YNL102W, YKL045W, and YNL262W) annotated with “DNA synthesis involved in DNA repair” in the microarray data.
B, expression of genes annotated with “Replication fork protection”. “Replication fork protection” is a true differentially expressed GO term that
GSEA (Pearson), but not GSEA + MIMGO, was able to identify in the first set (“7 GO terms upregulated at 14 min, 21 min, 70 min, and 77 min”) of
Table 3. The vertical axis shows the expression of genes (YBR274W, YDL101C, YAL021C, YNL273W, and YCL061C) annotated with “Replication fork
protection” in the microarray data.
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involved in DNA repair” as a differentially expressed GO
term (Figure 5A). The expression of YKL113C and
YKL045W in Figure 5A showed a high correlation of
0.70 and 0.80, respectively, with the vector “0 0 1 1 0 0 0
0 0 0 1 1 0 0 0 0 0 0”. Conversely, YNL102W and
YNL262W in Figure 5A showed a low correlation of
0.14 and 0.32, respectively, with the vector “0 0 1 1 0 0 0
0 0 0 1 1 0 0 0 0 0 0”. Thus, GSEA (Pearson) could not
often identify true differentially expressed GO terms that
equally annotated genes with high correlation and genes
with low correlation with an ideal expression pattern
(see Additional file 2: Table S2 ). Consequently, GSEA(Pearson) showed a high GSEA q-value of 0.23 for
“DNA synthesis involved in DNA repair” (Figure 5A).
However, genes annotated to “DNA synthesis involved
in DNA repair” showed clearly concerted expression
across time-course microarray data (Figure 5A). Unlike
GSEA (Pearson), the quantitative expression difference of
genes annotated to a GO term between a microarray re-
sult and other microarray data is measured in “GSEA +
MIMGO”. Therefore, GSEA + MIMGO identified only 21
min and 28 min, which show the most concerted upregu-
lation, to be “microarray data with upregulation”.
On the other hand, GSEA (Pearson), but not GSEA +
MIMGO, was able to identify “Replication fork protection”
Yamada et al. BMC Research Notes 2012, 5:680 Page 11 of 12
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annotated to “Replication fork protection” did not show
any clearly concerted upregulation across the time-course
microarray data compared with Figure 5A (Figure 5B). For
example, YDL101C and YCL061C, but not YBR274W,
YAL021C, and YNL273W, are significantly upregulated at
14 min compared with in other microarray data
(Figure 5B). This might explain why GSEA + MIMGO did
not identify “Replication fork protection” as a differentially
expressed GO term.
In contrast, YDL101C (r = 0.69), YCL061C (r = 0.63),
and YNL273W (r = 0.62), which show high correlation
with the ideal expression pattern (0 0 1 1 0 0 0 0 0 0 1 1
0 0 0 0 0 0), might result in a relatively low q-value of
0.0099 in GSEA(Pearson) for “Replication fork protec-
tion” (Figure 5B). Although YNL273W did not show any
remarkable upregulation across the microarray data, un-
like YDL101C and YCL061C, its expression pattern
across the microarray data was similar to the ideal ex-
pression pattern. Thus, concerted and large expression
differences in genes between microarray data are not ne-
cessary important for GSEA (Pearson), unlike for GSEA
+ MIMGO. These differences between GSEA + MIMGO
and GSEA (Pearson) may contribute to the slightly su-
perior power of GSEA (Pearson) in the detection of true
differentially expressed GO terms.
All the true differentially expressed GO terms used in
this study and the expression of their associated genes
in the yeast cell cycle microarray data are described in
Additional file 2: Table S2).
In summary, GSEA + MIMGO was able to correctly
identify microarray data in which genes annotated to dif-
ferentially expressed GO terms were upregulated (average
correlation ≥ 0.65 (p < 0.05)). However, stricter thresholds
in equation (2) may have to be applied to GSEA +
MIMGO to avoid false-positive identification of differen-
tially expressed GO terms at a higher GSEA q-value
threshold. In addition, MIMGO should be performed only
when a matrix such as that in Figure 3A has a sufficient
number of cells marked with 1. Otherwise, the use of a
lower q-value threshold for GSEA could result in the mis-
identification of differentially expressed GO terms, be-
cause this often leads to few cells marked with 1 in a
matrix such as that in Figure 3A.
GSEA + MIMGO is comparable to, or slightly less effect-
ive than, GSEA (Pearson) for the identification of true dif-
ferentially expressed GO terms. However, unlike other
methods including GSEA (Pearson), GSEA + MIMGO can
comprehensively identify differentially expressed GO terms
without pre-specification of the microarray data in which
genes annotated with a differentially expressed GO term
are upregulated or downregulated. Most often, researchers
cannot pre-select microarray data with a phenotype of
interest from a microarray dataset before gene set analysis.For example, researchers usually cannot pre-define micro-
array data in which gene sets are differentially expressed in
a time course- or a tissue-microarray dataset before gene
set analysis, because they hope to identify gene sets that are
differentially expressed in any microarray data of a micro-
array dataset. In such cases, GSEA + MIMGO is useful for
the identification of differentially expressed GO terms, be-
cause there is no need to pre-specify the microarray data in
which gene sets annotated with GO terms are upregulated
or downregulated before gene set analysis. Although the
ANOVA, MANOVA, and ANCOVA methods also do not
require pre-specification of the microarray data with a
phenotype of interest before gene set analysis, they cannot
identify microarray data in which gene sets are differentially
expressed, unlike GSEA + MIMGO [12,18]. On these
points, GSEA + MIMGO has advantages over other gene
set analysis methods.
Note that GSEA + MIMGO also has several drawbacks:
1) it does not give any correlation information between
differential expression and gene–gene relationships (e.g.,
pathways) within an a priori-defined and differentially
expressed gene set, in contrast to pathway analysis tools
such as ingenuity pathways analysis [19]; and 2) it assumes
the independence of genes within each pre-defined gene
set, but this assumption is false for microarray data: it does
not account for gene–gene correlation [20]. The reso-
lution of these drawbacks of GSEA + MIMGO is an issue
for the future.Additional files
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